I have been involved in healthcare innovation since 2003, for almost 18 years, as I concluded that the field would let me leverage my...

Tel Aviv, Israel, June 4, 2020 - Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased...

Introduction When 78-year-old Israeli cancer patient Lela Parnes stumbled upon the Alpha DaRT treatment in 2017, with information from a...

Tel Aviv, Israel -- Alpha Tau Medical – the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, and Medison Canada – a...

On November 28, 2019, the first Alpha DaRT procedure was performed in Russia, at the A. Tsyb Medical Radiological Research Center in...

In August 2018, Jonathan and Na’ama Ellman, an Israeli couple living in the United States, brought their two-year-old son Ari to the...

As the new Chief Medical Officer of Alpha Tau Medical, I passionately believe that the success of our new alpha-emitting radiation...

Diffusing alpha-emitters radiation therapy (DaRT) uses interstitial radioactive seeds that continually release short-lived alpha-emitting...

Cancer is the second leading cause of death in the United States. Around the globe, cancer incidence has been steadily increasing over...

Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...